Design Therapeutics, Inc. (DSGN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -16.43M | -11.97M | -11.16M | -14.44M | -16.79M | -9.86M | -9.55M | -11.26M | -12.44M | -12.8M | -14.53M | -13.8M | -17.42M | -15.09M | -13.9M | -10.5M | -11.83M | -9.23M | -8.16M | -8.29M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 2.13% | -21.36% | -16.93% | -28.25% | -34.97% | 22.96% | 34.32% | 18.43% | 28.61% | 15.19% | -4.57% | -31.47% | -47.32% | -63.55% | -70.25% | -26.67% | -219.91% | -224.44% | - | - |
| Net Income | -17.64M | -16M | -17M | -19.08M | -17.71M | -13.65M | -13.04M | -11.79M | -11.11M | -11.84M | -15.79M | -19.94M | -19.29M | -17.34M | -17.7M | -15M | -13.27M | -11.06M | -11.32M | -7.64M |
| Depreciation & Amortization | 10K | 704K | 155K | 152K | 159K | 149K | 153K | 151K | 143K | 138K | 137K | 133K | 129K | 124K | 108K | 92K | 82K | 82K | 31K | 12K |
| Stock-Based Compensation | 3.92M | 3.44M | 3.59M | 3.98M | 3.54M | 3.47M | 3.12M | 3.3M | 3.18M | 2.72M | 3.22M | 3.72M | 3.43M | 3.08M | 2.87M | 2.62M | 2.36M | 1.56M | 1.24M | 1.24M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.73M | -1.07M | -774K | -489K | -1.06M | -1.44M | -1.46M | -1.57M | -1.73M | -1.83M | -1.7M | -1.39M | -1.13M | -888K | -444K | -33K | 33K | 40K | 30K | 22K |
| Working Capital Changes | 0 | 960K | 2.86M | 994K | -1.71M | 1.61M | 1.68M | -1.35M | -2.93M | -1.99M | -400K | 3.67M | -553K | -63K | 1.27M | 1.82M | -1.04M | 160K | 1.85M | -1.93M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.51M | 1.84M | 2.4M | 542K | -301K | 1.01M | 1.02M | -720K | -2.52M | -2.81M | 239K | 3.07M | -1.75M | 408K | 3.17M | 1.61M | 200K | -41K | 1.38M | -301K |
| Cash from Investing | -7.59M | -11.58M | 6.51M | 20.12M | 7.87M | 1.83M | -5.83M | 27.33M | 20.62M | 5.55M | 15.27M | 11.98M | 19.73M | -1.06M | -63.39M | -156.96M | 414K | -50.06M | -5.04M | -21.57M |
| Capital Expenditures | 0 | -34K | 0 | -87K | -72K | 0 | 16K | -161K | -195K | -27K | -53K | -89K | -87K | -288K | -310K | -244K | -76K | -354K | -968K | -183K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.82K | 0 | 0 | 39K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.82K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 19.93M | 25.32M | 37K | 361K | 23K | 263K | 1K | 229K | 20K | 501K | 13K | 210K | 0 | 130K | 151K | 225K | 156K | 193K | 30K | 5K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 25.32M | 37K | 361K | 23K | 263K | 1K | 229K | 20K | 501K | 13K | 210K | 0 | 130K | 151K | 225K | 156K | 193K | 30K | 5K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 19.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -4.09M | 1.77M | -4.62M | 6.04M | -8.9M | -7.76M | -15.37M | 16.3M | 8.2M | -6.74M | 745K | -1.61M | 2.31M | -16.02M | -77.14M | -167.66M | -11.26M | -59.09M | -13.18M | -29.86M |
| Free Cash Flow | -16.43M | -12M | -11.16M | -14.53M | -16.86M | -9.86M | -9.53M | -11.42M | -12.63M | -12.82M | -14.59M | -13.89M | -17.51M | -15.38M | -14.21M | -10.74M | -11.9M | -9.58M | -9.13M | -8.47M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 2.55% | -21.7% | -17.12% | -27.2% | -33.46% | 23.12% | 34.67% | 17.79% | 27.85% | 16.61% | -2.66% | -29.31% | -47.11% | -60.52% | -55.6% | -26.82% | -219.12% | -235.23% | - | - |
| FCF per Share | -0.27 | -0.21 | -0.20 | -0.26 | -0.30 | -0.17 | -0.17 | -0.20 | -0.22 | -0.23 | -0.26 | -0.25 | -0.31 | -0.28 | -0.25 | -0.19 | -0.21 | -0.17 | -0.17 | -0.15 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.75x | 0.66x | 0.76x | 0.95x | 0.72x | 0.73x | 0.95x | 1.12x | 1.08x | 0.92x | 0.69x | 0.90x | 0.87x | 0.79x | 0.70x | 0.89x | 0.83x | 0.72x | 1.09x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |